This week, three U.S. senators and two U.S. representatives introduced bills in both houses of Congress that would require U ...
For the second time this year, the company is laying off workers, with its Fargo campuses feeling the impact the most.
A bipartisan group of U.S. lawmakers has introduced bills requiring firms to obtain a license before exporting synthetic DNA sequences. The aim is to protect American biotech innovations from foreign ...
Actinium Pharmaceuticals (ATNM) announced the presentation of new preclinical data for ATNM-400, its first-in-class Actinium-225 based antibody ...
Every December, I review the past 12 months and write about the things I learned. When I began writing this column 15 years ...
The data demonstrated that finite-duration 24-week AHB-137 monotherapy achieved a 30% functional cure rate at Week 72 (EOF) in patients with baseline HBsAg 100--1,000 IU/mL. This finding strengthens ...
Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...
Leading synthetic biologists have shared hard-won lessons from their decade-long quest to build the world's first synthetic ...
Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...
Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...
The German startup is developing ultrasensitive lateral flow diagnostic tests that incorporate DNA origami signal amplification.
If someone — like a disgruntled scientist, terror group, or rogue nation — were to synthesize and unleash smallpox, we could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback